Plättchenfunktionshemmer neue pharmakologische Ansätze
K Schrör - Hämostaseologie, 1991 - thieme-connect.com
Ziel der klinischen Therapie mit Thrombozytenfunktionshemmern ist eine Verhinderung von
thrombotischen Gefäßverschlüssen bei bestehendem erhöhten vaskulären Risiko. Aufgrund …
thrombotischen Gefäßverschlüssen bei bestehendem erhöhten vaskulären Risiko. Aufgrund …
Phosphotyrosine proteins in platelets from patients with storage pool disease: direct relation between granule defects and defective signal transduction
G Arderiu i Marquès, MI Diaz Ricart… - … , vol. 87, num. 6, p. 629 …, 2002 - diposit.ub.edu
Background and objectives: storage pool diseases (SPD) are heterogeneous disorders
associated with an abnormal presence of intraplatelet granules, which cause mild to …
associated with an abnormal presence of intraplatelet granules, which cause mild to …
[引用][C] Problem with aspirin as antithrombotic agent in coronary artery disease
JD Folts, GG Rowe, GHR Rao - The Lancet, 1988 - thelancet.com
[引用][C] Inhibition of platelet function in vivo or in vitro by organic nitrates
JD Folts - Journal of the American College of Cardiology, 1991 - jacc.org
Organic nitrates have been used to relieve angina since Brunton (l) first described their use
in 1867. The assumption has been that nitrates decrease myocardial oxygen demand by …
in 1867. The assumption has been that nitrates decrease myocardial oxygen demand by …
[引用][C] Application of liquid radiochromatographic techniques to the metabolic profiling of xenobiotically-mediated arachidonate metabolism
G Bioque, I Ramis, J Rosello-Catafau… - … of pharmaceutical and …, 1991 - Elsevier
Numerous in vitro studies have established the capacity of macrophages to metabolize
arachidonic acid (AA) to a variety of biologically active compounds [1]. These include …
arachidonic acid (AA) to a variety of biologically active compounds [1]. These include …
[引用][C] Chronic sinus node disease and coronary artery disease
TO Cheng - The Lancet, 1988 - thelancet.com
[引用][C] Thrombolytic therapy for myocardial infarction.
AJ McNeill, AA Adgey - Lancet (London, England), 1988 - europepmc.org
Thrombolytic therapy for myocardial infarction. - Abstract - Europe PMC Sign in | Create an
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …
account https://orcid.org Europe PMC Menu About Tools Developers Help Contact us Helpdesk …
[引用][C] Oral session V: Cerebrovascular disease I
DF Woimant, P Le Coz, E Assouline, F Gelbert, G Ast - Springer
In 80 patients (46 women, 34 men) with spontaneous extracranial ICAD seen at Mayo
Clinical before mid 1986, mean age 44.5 years and mean duration of follow-up was 73 …
Clinical before mid 1986, mean age 44.5 years and mean duration of follow-up was 73 …
[引用][C] GUNDU HR RAO', LEOPOLDO RAIJ², BRUCE B. LESTER'AND JAMES G. WHITE³
JG WHITE - Nitric Oxide from L-arginine: A Bioregulatory System …, 1990 - Excerpta Medica